Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C

Science. 1990 Mar 2;247(4946):1074-7. doi: 10.1126/science.2408147.

Abstract

Several immunologically distinct isozymes of inositol phospholipid-specific phospholipase C (PLC) have been purified from bovine brain. Murine NIH 3T3 fibroblasts were found to express PLC-gamma, but the expression of PLC-beta was barely detectable by radioimmunoassay or protein immunoblot. A mixture of monoclonal antibodies was identified that neutralizes the biological activity of both endogenous and injected purified PLC-gamma. When co-injected with oncogenic Ras protein or PLC-gamma, this mixture of antibodies inhibited the induction of DNA synthesis that characteristically results from the injection of these proteins into quiescent 3T3 cells. However, when oncogenic Ras protein or PLC-gamma was co-injected with a neutralizing monoclonal antibody to Ras, only the DNA synthesis induced by the Ras protein was inhibited--that induced by PLC was unaffected. These results suggest that the Ras protein is an upstream effector of PLC activity in phosphoinositide-specific signal transduction and that PLC-gamma activity is necessary for Ras-mediated induction of DNA synthesis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Cell Line
  • DNA / biosynthesis*
  • Fibroblasts
  • Growth Substances / pharmacology
  • Hybridomas
  • Immunoblotting
  • Interphase
  • Isoenzymes / immunology
  • Isoenzymes / metabolism*
  • Microinjections
  • Oncogene Protein p21(ras) / immunology
  • Oncogene Protein p21(ras) / pharmacology*
  • Radioimmunoassay
  • Signal Transduction
  • Type C Phospholipases / immunology
  • Type C Phospholipases / metabolism*
  • Type C Phospholipases / pharmacology

Substances

  • Antibodies, Monoclonal
  • Growth Substances
  • Isoenzymes
  • DNA
  • Type C Phospholipases
  • Oncogene Protein p21(ras)